Inventor · disambiguated record
Tove Olafsen
Also filed as: OLAFSEN TOVE
13 granted patents·11 pending applications·104 citations·filing 2007–2021
91Inventor score
Top patents by PatentIndex Score
24 records- 0193US8772459B2J591 minibodies and Cys-diabodies for targeting human prostate specific membrane antigen (PSMA) and methods for their useHO DAVID·Filed 2010·Granted Jul 8, 2014·47 cites·18 claims
- 0292US10414820B2Antigen binding constructs to CD8IMAGINAB INC·Filed 2014·Granted Sep 17, 2019·16 cites·21 claims
- 0391US10377826B2Antigen binding constructs to CD8IMAGINAB INC·Filed 2016·Granted Aug 13, 2019·5 cites·20 claims
- 0490US10882909B2Antigen binding constructs to CD3IMAGINAB INC·Filed 2019·Granted Jan 5, 2021·5 cites·10 claims
- 0589US11254744B2Antigen binding constructs to target moleculesIMAGINAB INC·Filed 2016·Granted Feb 22, 2022·5 cites·32 claims
- 0689US10301389B2Antigen binding constructs to CD3IMAGINAB INC·Filed 2013·Granted May 28, 2019·11 cites·9 claims
- 0786US7727525B2Engineered anti-CD20 antibody fragments for in vivo targeting and therapeuticsHOPE CITY·Filed 2007·Granted Jun 1, 2010·7 cites·5 claims
- 0884US11266745B2Extension sequences for diabodiesIMAGINAB INC·Filed 2018·Granted Mar 8, 2022·3 cites·25 claims
- 0981US11180570B2J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (PSMA) and methods for their useIMAGINAB INC·Filed 2019·Granted Nov 23, 2021·1 cites·18 claims
- 1081US9701754B1Covalent disulfide-linked diabodies and uses thereofWU ANNA M·Filed 2010·Granted Jul 11, 2017·2 cites·2 claims
- 1179US9765155B2Covalent disulfide-linked diabodies and uses thereofWU ANNA M·Filed 2012·Granted Sep 19, 2017·2 cites·1 claims
- 1272US2019382488A1Antigen binding constructs to cd8IMAGINAB INC·Filed 2019·Application pending·0 cites
- 1372US2019382487A1Antigen binding constructs to cd8IMAGINAB INC·Filed 2019·Application pending·0 cites
- 1471US2022135698A1J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their useIMAGINAB INC·Filed 2021·Application pending·0 cites
- 1570US12435141B2Antigen binding constructs to CD8IMAGINAB INC·Filed 2020·Granted Oct 7, 2025·0 cites·20 claims
- 1664US2022089730A1Antigen binding constructs to target moleculesIMAGINAB INC·Filed 2021·Application pending·0 cites
- 1762US2018155449A1Covalent disulfide-linked diabodies and uses thereofHOPE CITY·Filed 2017·Application pending·0 cites
- 1861US2014234215A1J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their useIMAGINAB INC·Filed 2014·Application pending·0 cites
- 1958US2015044694A1Engineered antibody-nanoparticle conjugatesUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 2057US2010069616A1Engineered antibody-nanoparticle conjugatesUNIV CALIFORNIA·Filed 2009·Application pending·0 cites
- 2153US12371497B2Antigen binding constructs to CD4IMAGINAB INC·Filed 2019·Granted Jul 29, 2025·0 cites·19 claims
- 2251US2012076728A1Human protein scaffold with controlled serum pharmacokineticsWU ANNA M·Filed 2010·Application pending·0 cites
- 2347US2016083450A1Human protein scaffold with controlled serum pharmacokineticsUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
- 2445US2015191543A1Engineered antibody fragments for targeting and imaging cd8 expression in vivoUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tove Olafsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →